RHEOFLUX 3500 mg/7 ml, oral solution in an ampoule 10 ampoules of 7 ml
Active ingredients: TROXÉRUTINE
Commercialized according to BDPM
Oral solution10 ampoules of 7 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- RHEOFLUX 3500 mg/7 ml, solution buvable en ampoule
- Pharmaceutical form
- solution buvable
- Route of administration
- orale
- Presentation description
- 10 ampoule(s) en verre jaune(brun) de 7 ml
- Marketing authorisation holder
- ETHYX PHARMACEUTICALS
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 29 Nov 2023
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64272162CIP73362778CIP133400933627782Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TROXÉRUTINEsolution | 3500 mg · une ampoule de 7 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.